Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes

Journal of Infectious Diseases

Volumn 182, Issue 5, 2000, Pages 1486-1496

  Nardin, Elizabeth H ^a   Oliveira, Giane A ^a   Calvo Calle, J Mauricio ^a   Castro, Z Rosa ^a   Nussenzweig, Ruth S ^a   Schmeckpeper, Barbara ^b   Hall, B Fenton ^d   Diggs, Carter ^f   Bodison, Sacared ^e   Edelman, Robert ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c University of Maryland School of Medicine Center for Vaccine Development   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

^f UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; MALARIA VACCINE; SYNTHETIC PEPTIDE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DRUG SAFETY; FEMALE; GENOTYPE; HLA SYSTEM; HUMAN; IMMUNOGENICITY; MALARIA; MALE; PHENOTYPE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ADULT; ANIMAL; ANTIBODIES, PROTOZOAN; COHORT STUDIES; FEMALE; GENOTYPE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMAN; MALARIA VACCINES; MALE; PLASMODIUM FALCIPARUM; SAPONINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VACCINES, SYNTHETIC;

EID: 0033787408     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315871     Document Type: Article

References (40)

1. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection
2. Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax
3. Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites
4. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites
5. Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria
6. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine
7. Multiple antigen constructs (MACs): Induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii
8. Protective immunity induced in squirrel monkeys with a multiple antigen construct against the circumsporozoite protein of Plasmodium vivax
9. Malaria vaccine: Immunization of mice with a synthetic T helper epitope alone leads to protective immunity
10. + T cell- and IFN-γ-dependent elimination of infected hepatocytes
11. Inhibition of development of exoerythrocytic forms of malaria parasites by gamma interferon
12. - clones from a malaria-immunized volunteer
13. Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein
14. Preclinical evaluation of a synthetic Plasmodium falciparum MAP malaria vaccine in Aotus monkeys and mice
15. Immunogenicity of an alum-adsorbed synthetic multiple-antigen peptide based on B- and T-cell epitopes of the Plasmodium falciparum CS protein: Possible vaccine application
16. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: Identification of a universal T cell epitope in the P. falciparum CS protein
17. Malaria antigens and MHC restriction
18. Precise prediction of major histocompatibility complex class II peptide interaction based on peptide side chain scanning
19. Eleventh international histocompatibility workshop reference protocol for the HLA DNA-typing technique
20. Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine
21. GM2-KLH conjugate vaccine: Increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21
22. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. V. In vitro effects of immune serum on sporozoites
23. Immunity to falciparum and vivax malaria induced by irradiated sporozoites: A review of the University of Maryland studies, 1971-75
24. Preparation of clinical grade proteins produced by recombinant DNA technologies
25. Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax
26. Successful immunization of humans with irradiated malaria sporozoites: Humoral and cellular responses of the protected individuals
27. Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine
28. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination
29. Immunogenetic mechanisms of antibody response to measles vaccine: The role of HLA genes
30. Association between HLA type and antibody response to malaria sporozoite and gametocyte epitopes is not evident in immune Papua New Guineans
31. MHC and malaria: The relationship between HLA class II alleles and immune responses to Plasmodium falciparum
32. Genetic control of the antibody response. II. Further analysis of the specificity of determinant specific control and genetic analysis of the response to (H,G)-A-L in CBA and C57 mice
33. A synthetic peptide administered with IL-12 elicits immunity to Listeria monocytogenes
34. Plasmodium berghei sporozoite invasion is blocked in vitro by sporozoite-immobilizing antibodies
35. TRAP is necessary for gliding motility and infectivity of Plasmodium sporozoites
36. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria
37. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine
38. Plasmodium falciparum polyoximes: Highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein
39. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types
40. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices